1. Home
  2. HQY vs ARWR Comparison

HQY vs ARWR Comparison

Compare HQY & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HealthEquity Inc.

HQY

HealthEquity Inc.

HOLD

Current Price

$84.31

Market Cap

7.9B

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$61.66

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HQY
ARWR
Founded
2002
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
8.0B
IPO Year
2014
2009

Fundamental Metrics

Financial Performance
Metric
HQY
ARWR
Price
$84.31
$61.66
Analyst Decision
Buy
Strong Buy
Analyst Count
14
10
Target Price
$114.64
$81.50
AVG Volume (30 Days)
875.5K
2.0M
Earning Date
03-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
125.69
99.80
EPS
2.46
0.22
Revenue
$229,525,000.00
$16,142,321.00
Revenue This Year
$8.42
N/A
Revenue Next Year
$8.43
N/A
P/E Ratio
$33.88
$286.36
Revenue Growth
28.68
N/A
52 Week Low
$72.76
$10.66
52 Week High
$116.65
$76.76

Technical Indicators

Market Signals
Indicator
HQY
ARWR
Relative Strength Index (RSI) 60.47 54.23
Support Level $82.74 $60.60
Resistance Level $98.61 $66.37
Average True Range (ATR) 2.67 3.03
MACD 0.47 0.81
Stochastic Oscillator 90.43 69.31

Price Performance

Historical Comparison
HQY
ARWR

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Share on Social Networks: